Darko Stevanovic

Darko Stevanovic, MD, PhD, is currently a Senior Director and Clinical Development Lead for Cardio-Renal-Metabolic Diseases at Boehringer Ingelheim, overseeing clinical development plans and trial designs since December 2024. With a robust background in clinical development gleaned from previous roles at Sarepta Therapeutics, Nova Biomedical, and Teva Pharmaceuticals, Stevanovic has extensive experience in medical strategy, cross-functional collaboration, and regulatory affairs. Stevanovic holds a Doctor of Philosophy in Medicine and a Doctor of Medicine degree from the University of Belgrade, along with additional training in translational medicine and leadership from Harvard University. Throughout an academic career that included positions as Research Fellow and Assistant Professor, Stevanovic has contributed significantly to the fields of endocrinology and medical physiology.